Your browser is no longer supported. Please, upgrade your browser.
Settings
TMDX [NASD]
TransMedics Group, Inc.
Index- P/E- EPS (ttm)-1.20 Insider Own1.70% Shs Outstand27.16M Perf Week-9.09%
Market Cap726.72M Forward P/E- EPS next Y-0.60 Insider Trans-69.92% Shs Float25.29M Perf Month-42.71%
Income-28.70M PEG- EPS next Q-0.29 Inst Own80.60% Short Float3.85% Perf Quarter36.18%
Sales25.60M P/S28.39 EPS this Y50.70% Inst Trans-2.13% Short Ratio1.04 Perf Half Y99.77%
Book/sh3.83 P/B6.79 EPS next Y43.90% ROA-20.10% Target Price- Perf Year65.77%
Cash/sh4.50 P/C5.78 EPS next 5Y- ROE-30.80% 52W Range11.51 - 49.50 Perf YTD30.70%
Dividend- P/FCF- EPS past 5Y- ROI-19.10% 52W High-47.45% Beta-
Dividend %- Quick Ratio11.40 Sales past 5Y- Gross Margin64.90% 52W Low125.98% ATR3.56
Employees110 Current Ratio12.40 Sales Q/Q24.60% Oper. Margin- RSI (14)30.97 Volatility6.70% 9.97%
OptionableYes Debt/Eq0.33 EPS Q/Q46.40% Profit Margin- Rel Volume0.69 Prev Close27.03
ShortableYes LT Debt/Eq0.33 EarningsMar 02 AMC Payout- Avg Volume937.87K Price26.01
Recom2.00 SMA20-29.58% SMA50-25.75% SMA20022.35% Volume644,492 Change-3.77%
Oct-08-20Downgrade JP Morgan Overweight → Neutral $15
Apr-07-20Initiated Oppenheimer Outperform $25
May-28-19Initiated Morgan Stanley Equal-Weight
May-28-19Initiated JP Morgan Overweight
May-28-19Initiated Cowen Outperform
May-28-19Initiated Canaccord Genuity Buy
Apr-15-21 05:30AM  
Apr-09-21 07:41AM  
Apr-07-21 08:50AM  
Apr-06-21 10:20PM  
05:30PM  
07:05AM  
Mar-24-21 04:05PM  
Mar-12-21 06:01AM  
Mar-10-21 01:00PM  
Mar-04-21 12:29AM  
Mar-02-21 05:35PM  
04:38PM  
04:01PM  
02:30PM  
Mar-01-21 04:15PM  
Feb-16-21 04:05PM  
04:01PM  
Feb-05-21 08:44AM  
Dec-24-20 08:00AM  
Dec-23-20 04:01PM  
Dec-07-20 04:06PM  
Nov-04-20 08:31PM  
06:45PM  
04:01PM  
02:30PM  
Oct-29-20 04:02PM  
03:00PM  
Oct-28-20 12:33PM  
Oct-21-20 04:01PM  
Oct-19-20 06:10PM  
Sep-28-20 04:05PM  
Sep-01-20 04:30PM  
Aug-05-20 04:01PM  
Jul-29-20 12:33PM  
Jul-28-20 04:01PM  
01:52PM  
Jul-23-20 08:00AM  
Jun-04-20 10:11PM  
May-27-20 11:14AM  
May-26-20 06:50PM  
07:14AM  
07:09AM  
May-07-20 11:30AM  
May-06-20 04:05PM  
Apr-29-20 12:34PM  
Apr-23-20 04:05PM  
Apr-13-20 04:05PM  
Mar-17-20 09:20AM  
07:00AM  
Mar-02-20 04:05PM  
Feb-20-20 04:05PM  
Feb-19-20 04:05PM  
Jan-17-20 09:39AM  
Dec-22-19 05:10PM  
Dec-19-19 08:00AM  
Dec-09-19 08:58AM  
Dec-04-19 08:00AM  
Nov-06-19 07:30AM  
Nov-01-19 02:17PM  
Oct-23-19 04:05PM  
Oct-16-19 04:05PM  
Sep-17-19 01:45PM  
Aug-26-19 04:05PM  
Aug-21-19 05:35PM  
Aug-07-19 04:05PM  
Aug-02-19 08:21AM  
Jul-30-19 08:30AM  
Jul-25-19 04:05PM  
Jul-17-19 04:05PM  
Jun-30-19 08:11AM  
Jun-11-19 04:05PM  
02:30PM  
Jun-03-19 08:00AM  
May-30-19 04:05PM  
May-06-19 04:15PM  
May-01-19 01:25PM  
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sullivan John FVP of Quality & EngineeringApr 07Option Exercise5.0015,00074,94025,828Apr 09 07:38 PM
Sullivan John FVP of Quality & EngineeringApr 07Sale36.8315,000552,39410,828Apr 09 07:38 PM
Carey John FVP of OperationsApr 05Option Exercise16.143,36054,2303,360Apr 07 06:34 PM
Hassanein Waleed HPresident & CEOApr 05Option Exercise0.28125,00035,000403,843Apr 07 06:35 PM
Carey John FVP of OperationsApr 05Sale36.873,360123,8830Apr 07 06:34 PM
Hassanein Waleed HPresident & CEOApr 01Sale40.6360,0002,437,871278,843Apr 05 06:17 PM
Gordon StephenChief Financial OfficerMar 15Option Exercise0.6710,0006,70010,000Mar 16 06:14 PM
Gordon StephenChief Financial OfficerMar 15Sale39.8110,000398,1000Mar 16 06:14 PM
Carey John FVP of OperationsMar 11Sale37.503,200120,0000Mar 11 09:19 PM
Hassanein Waleed HPresident & CEOMar 10Option Exercise2.2135,00777,365373,850Mar 11 09:17 PM
Hassanein Waleed HPresident & CEOMar 10Sale33.7935,0071,182,963338,843Mar 11 09:17 PM
Khayal Tamer IChief Commercial OfficerMar 08Option Exercise0.2820,0005,60066,076Mar 09 05:36 PM
Khayal Tamer IChief Commercial OfficerMar 08Sale32.0020,000640,00046,076Mar 09 05:36 PM
Khayal Tamer IChief Commercial OfficerMar 05Option Exercise0.3620,0007,20066,076Mar 09 05:36 PM
Khayal Tamer IChief Commercial OfficerMar 05Sale30.9020,000618,09946,076Mar 09 05:36 PM
Gordon StephenChief Financial OfficerFeb 16Option Exercise0.6710,0006,70010,000Feb 17 05:43 PM
Gordon StephenChief Financial OfficerFeb 16Sale31.3310,000313,3000Feb 17 05:43 PM
Sullivan John FVP of Quality & EngineeringFeb 09Option Exercise0.288,6002,40819,428Feb 11 08:57 AM
ABRAMS CAPITAL MANAGEMENT, L.P10% OwnerFeb 09Sale33.32786,66426,208,7342,624,712Feb 10 04:53 PM
TOBIN JAMES RDirectorFeb 09Sale32.8310,168333,786424,637Feb 10 06:59 PM
Sullivan John FVP of Quality & EngineeringFeb 09Sale32.818,600282,18810,828Feb 11 08:57 AM
Gordon StephenChief Financial OfficerFeb 08Option Exercise0.671,4299571,429Feb 10 07:00 PM
Gordon StephenChief Financial OfficerFeb 08Sale25.0110,000250,1000Feb 10 07:00 PM
ABRAMS CAPITAL MANAGEMENT, L.P10% OwnerFeb 08Sale26.2488,4832,321,7053,411,376Feb 10 04:53 PM
Sullivan John FVP of Quality & EngineeringJan 19Option Exercise0.399,6173,75120,445Jan 20 09:00 PM
Sullivan John FVP of Quality & EngineeringJan 19Sale22.129,617212,72810,828Jan 20 09:00 PM
Hassanein Waleed HPresident & CEOJan 05Option Exercise0.39123,41448,131338,843Jan 14 06:56 PM
Gordon StephenChief Financial OfficerJan 04Sale20.001,18423,6808,371Jan 05 06:04 PM
Gordon StephenChief Financial OfficerDec 31Sale20.008,816176,3209,755Jan 05 06:04 PM
Sullivan John FVP of Quality & EngineeringDec 21Sale17.991,00017,99010,828Dec 22 04:19 PM
Sullivan John FVP of Quality & EngineeringDec 16Option Exercise0.391,00039011,828Dec 17 05:57 PM
Sullivan John FVP of Quality & EngineeringDec 15Option Exercise0.393,0001,17013,828Dec 17 05:57 PM
Sullivan John FVP of Quality & EngineeringDec 15Sale16.633,00049,89010,828Dec 17 05:57 PM
Provost MiriamVP of US Regulatory & FDA Rel.Dec 11Option Exercise3.224,60014,8124,600Dec 14 04:53 PM
Carey John FVP of OperationsSep 01Option Exercise0.392,0007805,200Sep 03 06:41 PM
Carey John FVP of OperationsSep 01Sale17.592,00035,1803,200Sep 03 06:41 PM
Carey John FVP of OperationsAug 03Option Exercise2.212,0004,4205,200Aug 05 08:08 PM
Carey John FVP of OperationsAug 03Sale18.612,00037,2143,200Aug 05 08:08 PM
Carey John FVP of OperationsJul 01Option Exercise1.402,0002,7935,200Jul 02 07:42 PM
Carey John FVP of OperationsJul 01Sale17.092,00034,1743,200Jul 02 07:42 PM
Carey John FVP of OperationsJun 01Option Exercise0.392,0007805,200Jun 02 06:10 PM
Carey John FVP of OperationsJun 01Sale13.212,00026,4203,200Jun 02 06:10 PM
Carey John FVP of OperationsMay 01Option Exercise0.392,0007805,200May 04 06:04 PM
Carey John FVP of OperationsMay 01Sale17.052,00034,1053,200May 04 06:04 PM
Gordon StephenChief Financial OfficerApr 27Sale18.009,900178,20018,571Apr 29 04:22 PM
Gordon StephenChief Financial OfficerApr 22Sale18.001001,80028,471Apr 24 05:54 PM